Posted on by ScienceFather
71 / 100
Powered by Rank Math SEO

Dr. Anh Tran | Health economics | Women Researcher Award

Dr. Anh Tran, NHMRC Clinical Trials Centre, Australia

Dr. Anh Tran is a Senior Research Fellow in Health Economics at the University of Sydney’s NHMRC Clinical Trials Centre. With expertise spanning health economics, public health, and pharmacy, Dr. Tran holds a PhD from the University of New South Wales. 🎓 His research focuses on cost-effectiveness evaluations in various healthcare domains, including HIV treatment and substance abuse interventions. 🩺 Dr. Tran’s extensive publication record and leadership in grant-funded projects underscore his commitment to advancing evidence-based healthcare policy. As an accomplished educator, he also contributes to teaching and supervising students in health economics and public health. 📚

Publication Profile:

Scopus

Orcid

Education:

Dr. Anh Tran’s academic journey reflects a diverse background in health economics and public health. 🎓 He obtained his PhD in Health Economics from the University of New South Wales, where his research delved into the cost-effectiveness of antiretroviral initiation treatment thresholds for HIV patients. Prior to this, he earned a Master of Public Health from the University of Queensland, focusing on the completeness of vital registration in Vietnam. Dr. Tran’s educational foundation also includes a Bachelor of Pharmacy from Hanoi University of Pharmacy, Vietnam, where he explored the economic evaluation of pharmaceutical companies in Hanoi. 🏥

 

Teaching Experience :

Dr. Anh Tran brings his expertise in health economics and pharmacy to the classroom, enriching the learning experiences of students. 📚 At the University of Sydney’s Pharmacy School, he serves as a Guest Lecturer for courses like Pharmacy Services and Public Health (PHAR 4823) and Pharmacy Public Health (PHAR 5725), engaging approximately 125 and 70 students per semester, respectively. Additionally, he spearheads Advanced Health Economics and Financial Management (PHCM9082) since 2019. Dr. Tran’s commitment to education extends beyond Sydney; he previously served as a Course Coordinator for Pharmacoeconomics at the Hanoi School of Pharmacy from 2007 to 2009. 🎓

 

Research Focus:

Dr. Anh Dam Tran’s research focus spans across health economics, public health, and pharmacoeconomics, with a particular emphasis on health-related quality of life, cost-effectiveness analysis, and healthcare interventions. 📊 His work encompasses diverse areas such as HIV/AIDS treatment strategies, screening and treatment approaches for various diseases, and the economic implications of healthcare interventions. Through systematic reviews, observational studies, and economic analyses, Dr. Tran contributes valuable insights into optimizing healthcare delivery and resource allocation, ultimately aiming to improve health outcomes and quality of life for individuals and communities. 🌟

Publication Top Notes:

Health utility among people who regularly use opioids in Australia

Health utilities among Aboriginal people attending residential rehabilitation services in New South Wales, Australia: An observational follow‐up study

Cost Analysis of Adjuvant Whole-Brain Radiotherapy Treatment Versus No Whole-Brain Radiotherapy After Stereotactic Radiosurgery and/or Surgery Among Adults with One to Three Melanoma Brain Metastases: Results from a Randomized Trial

Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions

Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross-sectional survey of Australian treatment clients

Impact and return on investment of the take kare safe space program—a harm reduction strategy implemented in Sydney, Australia

Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: A systematic review

Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis

Cost-Effectiveness of Subsequent Whole-Brain Radiotherapy or Hippocampal-Avoidant Whole-Brain Radiotherapy Versus Stereotactic Radiosurgery or Surgery Alone for Treatment of Melanoma Brain Metastases.

Effectiveness of screening and treatment approaches for schistosomiasis and strongyloidiasis in newly-arrived migrants from endemic countries in the EU/EEA: A systematic review

 

 

 

 

 

Anh Tran | Health economics | Women Researcher Award

You May Also Like